phase readout
saveNCT07257055: Phase 2 Study of BTKi-Rituximab Induction Followed by Glofitamab Consolidation in High Risk Untreated MCL Patients - WINDOW-4 Study
RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Phase 2 Study, MCL, BTKi, Rituximab, Glofitamab
view source ↗
comments(0)
5-min edit window · permanent after that